A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)
一项评估硼替佐米和脂质体阿霉素治疗 BRCA 野生型铂耐药复发性卵巢癌患者疗效的 II 期试验 (KGOG 3044/EBLIN)
期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.12917
Lee, Yong Jae; Seol, Aeran; Lee, Maria; Kim, Jae-Weon; Kim, Hee Seung; Kim, Kidong; Suh, Dong Hoon; Kim, Sunghoon; Kim, Sang Wun; Lee, Jung-Yun